Strasbourg, France, April 24, 2025, 8:00 a.m. CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies, announced that the documentation related to the Combined General Meeting (ordinary and extraordinary sessions) of Transgene’s shareholders is available.
Availability of Preparatory Documents for the Combined General Meeting of May 15, 2025
Seeking Alpha / 55 minutes from now 1 Views
Comments